Viewing Study NCT02154308


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-13 @ 5:25 PM
Study NCT ID: NCT02154308
Status: COMPLETED
Last Update Posted: 2014-06-03
First Post: 2014-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults
Sponsor: Il-Yang Pharm. Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-11
Start Date Type: None
Primary Completion Date: 2013-03
Primary Completion Date Type: ACTUAL
Completion Date: 2013-08
Completion Date Type: ACTUAL
First Submit Date: 2014-05-30
First Submit QC Date: None
Study First Post Date: 2014-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-06-02
Last Update Post Date: 2014-06-03
Last Update Post Date Type: ESTIMATED